跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
REVOLADE eltrombopag 25mg film-coated tablet blister pack
Approved
STANDARD
REVOLADE eltrombopag 25mg film-coated tablet blister pack
Novartis Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
240e9d933d09918c
Company
Novartis Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
240e9d933d09918c
Product Name
REVOLADE eltrombopag 25mg film-coated tablet blister pack
Artg Id
158419
Artg Name
REVOLADE eltrombopag 25mg film-coated tablet blister pack
Sponsor
Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date
2010-07-16
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2011-CMI-01378-3
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2011-PI-01377-3
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
240e9d933d09918c
Type
Standard
Back to TGA Approvals
REVOLADE eltrombopag 25mg film-coated tablet blister pack - TGA Drug Approval Details